Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
MANALIPETC

Manali Petrochemicals Share Price

 
Stock is trading on High Volume

 

Manali Petrochemicals live price: ₹62.94. It opened at ₹58 vs previous close ₹56; intraday high/low: ₹67/₹57. The 50 & 200 DMA stand at ₹54.39/₹58.69.

Manali Petrochemicals Performance

  • Today's Low
  • ₹57
  • Today's High
  • ₹67
  • 52 Week Low
  • ₹39
  • 52 Week High
  • ₹81
  • Open Price₹58
  • Previous Close₹56
  • Volume18,815,503
  • 50 DMA₹54.39
  • 100 DMA₹55.60
  • 200 DMA₹58.69

Manali Petrochemicals Chart

Investment Returns

  • Over 1 Month + 16.21%
  • Over 3 Month + 14.04%
  • Over 6 Month -3.94%
  • Over 1 Year + 11.66%

Smart Investing Starts Here Start SIP with Manali Petrochemicals for Steady Growth!

Invest Now

Manali Petrochemicals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 8.3
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 1,083
  • P/B Ratio
  • 0.9
  • Average True Range
  • 2.88
  • EPS
  • 4.13
  • Dividend Yield
  • 0.8
  • MACD Signal
  • 1.33
  • RSI
  • 70.22
  • MFI
  • 94.09

Latest Stock News Updates

Q4FY26 & FY26 Result Announced for Manali Petrochemicals Ltd.

Petrochemicals company Manali Petrochemicals announced Q4FY26 & FY26 results Standalone Financial Highlights: Revenue from Operations: Q4FY26: Rs 24,780 lakh, compared to Rs 19,514 lakh in Q3FY26 (QoQ increase of 27%) and Rs 16,327 lakh in Q4FY25 (YoY increase of 51.77%). FY26: Rs 78,634 lakh, compared to Rs 64,751 lakh in FY25 (YoY increase of 21.44%). Total Income: Q4FY26: Rs 25,671 lakh, compared to Rs 20,614 lakh in Q3FY26 (QoQ increase of 24.53%) and Rs 17,313 lakh in Q4FY25 (YoY increase of 48.27%). FY26: Rs 82,173 lakh, compared to Rs 66,927 lakh in FY25 (YoY increase of 22.79%). Net Profit for the Period/Year: Q4FY26: Rs 2,701 lakh, compared to Rs 455 lakh in Q3FY26 (QoQ increase of 493.63%) and Rs 308 lakh in Q4FY25 (YoY increase of 776.95%). FY26: Rs 3,476 lakh, compared to a net loss of Rs 874 lakh in FY25. Consolidated Financial Highlights: Revenue from Operations: Q4FY26: Rs 29,266 lakh, compared to Rs 24,702 lakh in Q3FY26 (QoQ increase of 18.48%) and Rs 23,036 lakh in Q4FY25 (YoY increase of 27.04%). FY26: Rs 1,02,239 lakh, compared to Rs 89,712 lakh in FY25 (YoY increase of 13.96%). Total Income: Q4FY26: Rs 29,943 lakh, compared to Rs 26,680 lakh in Q3FY26 (QoQ increase of 12.23%) and Rs 23,834 lakh in Q4FY25 (YoY increase of 25.63%). FY26: Rs 1,06,985 lakh, compared to Rs 92,163 lakh in FY25 (YoY increase of 16.08%). Profit for the Period/Year: Q4FY26: Rs 2,904 lakh, compared to Rs 6,843 lakh in Q3FY26 (QoQ decrease of 57.56%) and Rs 1,081 lakh in Q4FY25 (YoY increase of 168.64%). FY26: Rs 12,995 lakh, compared to Rs 2,931 lakh in FY25 (YoY increase of 343.36%). Business Highlights: Dividend: The Board recommended a final dividend of Rs 0.50 per equity share of Rs 5 each (10%) for FY26, subject to approval at the ensuing Annual General Meeting. Directorate: Mr. Thanjavur Kanakaraj Arun has been re-appointed as an Independent Director for a second term of five years effective from September 29, 2026, subject to member approval. Exceptional Items: The Company received an insurance claim of Rs 816 lakh regarding stocks affected by floods (Cyclone Michaung) in October 2025. Gain on sale of a portion of land amounting to Rs 45.87 lakh was recorded. Customs duty cases related to imported raw materials were decided in the Company's favour by CESTAT, resulting in a provision reversal of Rs 770 lakh. A claim filed by an erstwhile customer was dismissed by the City Civil Court, Mumbai, in favour of the Company, leading to a provision reversal of Rs 1,083 lakh. Operational Update: The Company has completed the acquisition of Fetomat Wellness Private Limited in April 2025, which is now a subsidiary. Segment Reporting: The Company continues to be exclusively engaged in the manufacture and sale of petrochemical products primarily in India, and there are no reportable operating or geographical segments applicable. Ashwin Muthiah, Chairman, MPL & Founder Chairman, AM International, Singapore, said: Our last quarter performance has been good despite broader macroeconomic pressures, particularly rising input costs and unhindered imports. Improved rawmaterial efficiencies better realisations and contributions from our overseas subsidiaries supported the results. It reflects our continuous focus on internal cost discipline, productivity gains, and the strategic shift toward premium specialty chemical solutions. Given the ongoing geopolitical uncertainties, we remain cautiously optimistic in the near term.” Result PDF

Manali Petrochemicals Ltd consolidated Q4 profit more than doubles on exceptional gain

In Q4'26, the company gained on divestment of Notedome Limited and its subsidiary Notedome Europe GmbH, amounting to 52 crore

Manali Petrochemicals to restart Chennai plant operations

Operations at Plant-1 are expected to resume in a phased manne rupon receipt of propylene supplies from CPCL

Manali Petrochemicals Financials

Manali Petrochemicals Technicals

EMA & SMA

Current Price
₹62.94
+ 7.42 (13.36%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹55.97
  • 50 Day
  • ₹54.39
  • 100 Day
  • ₹55.60
  • 200 Day
  • ₹58.69

Resistance and Support

62.29 Pivot Speed
  • R3 76.58
  • R2 71.60
  • R1 67.27
  • S1 57.96
  • S2 52.98
  • S3 48.65

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Manali Petrochemicals manufactures petrochemical products, including propylene glycol, polyols, and foam additives. Serving industries such as automotive, construction, and pharmaceuticals, it has a strong presence in domestic and international markets with high-quality chemical solutions.

Manali Petrochemical has an operating revenue of Rs. 1,022.39 Cr. on a trailing 12-month basis. An annual revenue de-growth of -13% needs improvement, Pre-tax margin of 5% is okay, ROE of 2% is fair but needs improvement. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and around 8% up from its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 73 which is a FAIR score but needs to improve its earnings, a RS Rating of 45 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 50 indicates it belongs to a fair industry group of Chemicals-Specialty and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Manali Petrochemicals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-21 Audited Results & Dividend
2026-02-02 Quarterly Results
2025-11-10 Quarterly Results
2025-08-11 Quarterly Results
2025-05-13 Audited Results & Dividend
Date Purpose Remarks
2025-09-09 FINAL Rs.0.50 per share(10%)Dividend (RD dates revised)
View Manali Petrochemicals Dividend History Arrow

Manali Petrochemicals Shareholding Pattern

44.86%
0.01%
0%
0.37%
0%
39.2%
15.56%

Manali Petrochemicals FAQs

Manali Petrochemicals share price is ₹62 As on 24 May, 2026 | 17:24

The Market Cap of Manali Petrochemicals is ₹1082.6 Cr As on 24 May, 2026 | 17:24

The P/E ratio of Manali Petrochemicals is 8.3 As on 24 May, 2026 | 17:24

The PB ratio of Manali Petrochemicals is 0.9 As on 24 May, 2026 | 17:24

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23